Close

BIO comments on FDA proposed rule regarding disclosure of certain information in gene therapy and xenotransplantation experiments

he Biotechnology Industry Organization (BIO) is pleased to submit comments to the Food and Drug Administration (FDA) on the proposed rule "Availability for Public Disclosure and Submission to FDA for Public Disclosure of Certain Data and Information Related to Human Gene Therapy or Xenotransplantation." 66 Fed. Reg. 4688 (January 18, 2001) (the Proposed Rule or FDA’s Proposal).

Anything Under the Sun Made by Man

Consider this: We all know that Alexander Fleming discovered penicillin. Some of us know he did it in 1928. But how many people can tell you who Andrew J. Moyer is — and why penicillin didn't become commonly available until 1941?

TESTIMONY OF THOMAS OKARMA, MD, PhD PRESIDENT AND CEO OF GERON CORPORATION ON BEHALF OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) BEFORE THE SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS COMMITTEE ON ENERGY AND COMMERCE US HOUSE OF REPRESENTATIV

by Thomas Okarma, CEO, Geron, subcommittee on Oversight and Investigations

Stop, Look and Listen

Since biotechnology is still so mysterious to a lot of people it’s going to require our humility and society’s acceptance or permission, if you will, to fully reach that goal.

Letter to President George Bush Regarding Cloning

Letter to President George W. Bush

BIO Position on Stem Cell Research

As expressed in a joint letter to President-Elect Bush.

Recombinant DNA Research

Recombinant DNA Research, Proposed Actions Under the NIH Guidelines.

BIO Members Testify before House Judiciary Subcommittee

Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary subcommittee oversight hearing on gene patents and other genomic inventions.

BIO 2000 Opening Plenary Speech / Boston

We meet here in Boston at a truly remarkable moment in the relatively short but dramatic history of the biotechnology industry.

Testimony on the Proposed Rule on Confidentiality of Patient Records

Regarding the Proposed Rule on Confidentiality of Patient Records Could Impede Research before the Senate Health, Education, Labor and Pensions Committee.